Surveillance Study of Candiduria in Hospitalized Patients

October 5, 2020 updated by: Chen Ying-Chun, Taichung Veterans General Hospital

Retrospective Surveillance Study of Candiduria in Hospitalized Patients

The purpose of the study is to explore the epidemiology, underlying diseases, indwelling catheter duration, laboratory data, diagnosis, treatment and prognosis of patients with Candiduria.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The study is a retrospective study. Investigators will review medical records of patients with Candiduria from January 2015 to December 2017 to collect data about personal data, underlying diseases, indwelling catheter duration, laboratory data of urine routines and urine cultures, the symptom of fever, diagnosis, treatment and prognosis. After the data collection, investigators will run a descriptive statistics to find out the profile of the medical care of Candiduria in Taiwan.

Study Type

Observational

Enrollment (Actual)

536

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taichung, Taiwan, 40705
        • Taichung Veterans General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

all patients with Candiduria

Description

Inclusion Criteria:

  • patients with Candiduria

Exclusion Criteria:

  • patients without Candiduria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
prevalence rate of Candiduria
Time Frame: January 2015 to December 2017
the number of patients with Candiduria/ the number of all hospitalized patients
January 2015 to December 2017
morbidity rate of underlying diseases
Time Frame: January 2015 to December 2017
the proportion of patients with every specific underlying disease
January 2015 to December 2017
indwelling catheter rate
Time Frame: January 2015 to December 2017
the proportion of patients with indwelling catheter
January 2015 to December 2017
pyuria rate
Time Frame: January 2015 to December 2017
the proportion of patients with pyuria
January 2015 to December 2017
Candiduria rate
Time Frame: January 2015 to December 2017
the proportion of patients with Candiduria
January 2015 to December 2017
treatment rate
Time Frame: January 2015 to December 2017
the proportion of patients with Candiduria treated with antifungal agents
January 2015 to December 2017
mortality rate
Time Frame: January 2015 to December 2017
  1. the number of patients who die / the number of all hospitalized patients
  2. the number of patients who die from Candiduria/ the number of all hospitalized patients
January 2015 to December 2017
average indwelling catheter duration
Time Frame: January 2015 to December 2017
The sum of indwelling catheter durations / the number of all hospitalized patients with Candiduria
January 2015 to December 2017

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2019

Primary Completion (Actual)

July 31, 2020

Study Completion (Actual)

September 16, 2020

Study Registration Dates

First Submitted

April 7, 2019

First Submitted That Met QC Criteria

April 9, 2019

First Posted (Actual)

April 10, 2019

Study Record Updates

Last Update Posted (Actual)

October 8, 2020

Last Update Submitted That Met QC Criteria

October 5, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • CE18273B

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on no intervention

3
Subscribe